Prasugrel hydrochloride

Base Information

• Chemical Name: Prasugrel hydrochloride
• CAS No.: 389574-19-0
• Molecular Formula: C20H20FNO3S.HCl
• Molecular Weight: 409.90
• Hs Code.: 2934990002
• European Community (EC) Number: 627-126-4
• UNII: G89JQ59I13
• DSSTox Substance ID: DTXSID1049067
• Wikidata: Q27278929
• NCI Thesaurus Code: C81571
• RXCUI: 847020
• ChEMBL ID: CHEMBL1201773
• Mol file: 389574-19-0.mol

Synonyms:640315, LY;747, CS;CS 747;CS-747;CS747;Effient;efient;HCl, Prasugrel;Hydrochloride, Prasugrel;LY 640315;LY-640315;LY640315;prasugrel;Prasugrel HCl;Prasugrel Hydrochloride

Chemical Property of Prasugrel hydrochloride

Chemical Property:

• Appearance/Colour: White to off-white solid
• Vapor Pressure: 7.01E-10mmHg at 25°C
• Boiling Point: 493.5 °C at 760 mmHg
• Flash Point: 252.3 °C
• PSA: 74.85000
• LogP: 4.63090
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• Solubility.: Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly)
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 6
• Rotatable Bond Count: 6
• Exact Mass: 409.0914706
• Heavy Atom Count: 27
• Complexity: 555

Purity/Quality:

99%min ^*data from raw suppliers

Prasugrel Hydrochloride ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl
• Recent ClinicalTrials: Prasugrel in Severe COVID-19 Pneumonia
• Recent EU Clinical Trials: Ischemic and bleeding outcomes after angiolite stent implantation and an abbreviated dual antiplatelet therapy. A 2x2 factorial, all-comer, multicenter, randomized controlled trial: Angiodapt.
• Recent NIPH Clinical Trials: PRASTRO-III
• Uses: A novel antiplatelet agent; it is a third-generation thienopyridine. y induce increased incidence of bleeding in patient with acute coronary syndrome A novel antiplatelet agent; it is a third-generation thienopyridine. Antiplatelet agent Prasugrel showed greater platelet inhibition and decreased incidence of ischemic events than Clopidogrel but may induce increased incidence of bleeding in patient with acute coronary syndrome